IP Library Granted Patent US 7,125,885
Granted Patent B2
US 7,125,885 · App. 10/928,029 · Granted Oct 24, 2006

Fused heterocyclic compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,125,885
App. No.
10/928,029
Granted
Oct 24, 2006
Kind
B2
Abstract

The present invention provides compounds having the formula: wherein R 1 , R 2 , R, R′ and the subscript p are described herein. The compounds are useful in the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor. Pharmaceutical compositions and methods of using these compounds for the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor, such as eating disorder, obesity, anxiety disorders and mood disorders are also provided.

Claims (2)

1. A compound or a pharmaceutically acceptable salt, hydrate, solvate or prodrug thereof, wherein said compound is selected from the group consisting of:

2. A pharmaceutical composition comprising a pharmaceutically acceptable carrier or excipient and a compound of claim 1 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2005
From: AMGEN SF, LLC
To: AMGEN INC.
Reel/Frame 016871/0736 →
MERGER Recorded Jun 7, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 016309/0003 →
CHANGE OF NAME Recorded Jun 7, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 016309/0812 →